Search

everythinglearnresearchcommunity

for

Search:↓

14,15-EET may help reduce poststroke pain by affecting certain brain proteins.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Aromoline and DRD4 are potential targets for osteoarthritis treatment.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Precise objectives can improve student achievement in health education.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

ROR-alpha may increase the growth of certain breast cancer cells by boosting aromatase, which could affect breast cancer prognosis.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Activating δ-opioid receptors can help hair grow.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

Different types of androgens bind differently to two receptors, AR1 and AR2, in Atlantic croaker's brain and ovarian tissues, suggesting these receptors may control different androgen actions in fish.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

RORA boosts autophagy in hair follicle stem cells, potentially aiding hair growth.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Testosterone reduces knee movement, while flutamide and finasteride increase it.

Disruption of glycinergic circuits increases pain sensitivity, suggesting new pain treatment options.

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.